GSK plc
GSK
#222
Rank
NZ$182.26 B
Marketcap
NZ$90.93
Share price
-1.45%
Change (1 day)
10.40%
Change (1 year)

EPS for GSK plc (GSK)

EPS in 2026 (TTM): NZ$5.04

According to GSK plc's latest financial reports the company's current EPS (TTM) is NZ$5.19. In 2025 the company made an earnings per share (EPS) of NZ$6.80 an increase over its 2024 EPS that were of NZ$2.88.

EPS history for GSK plc from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$5.04-25.85%
2025NZ$6.80136.36%
2024NZ$2.88-47.35%
2023NZ$5.46-64.2%
2022NZ$15.26182.29%
2021NZ$5.40-18.07%
2020NZ$6.6022.34%
2019NZ$5.3923.9%
2018NZ$4.35140.61%
2017NZ$1.8164.45%
2016NZ$1.10-90.61%
2015NZ$11.71178.12%
2014NZ$4.21-48.11%
2013NZ$8.1122.68%
2012NZ$6.61-11.31%
2011NZ$7.46

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
NZ$9.47 82.46%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$1.37-73.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$3.43-33.87%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
NZ$1.79-65.50%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$12.05 132.16%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$1.14-78.10%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Dynavax Technologies
DVAX
NZ-$0.58-111.12%๐Ÿ‡บ๐Ÿ‡ธ USA